微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 38.33% | -3.38% | 16.04% | 24/52 | 36.36% | 百奥赛图 | 74.91% | 行业排名> |
| 2025-06-30 | 33.03% | -7.35% | 37.41% | 31/52 | 36.49% | 百奥赛图 | 74.39% | 行业排名> |
| 2025-03-31 | 24.04% | -14.27% | -43.81% | 41/52 | 34.34% | *ST生物 | 64.96% | 行业排名> |
| 2024-12-31 | 42.78% | -0.01% | 7.84% | 17/52 | 35.25% | 百奥赛图 | 77.67% | 行业排名> |
| 2024-09-30 | 39.67% | -0.87% | 11.27% | 24/52 | 35.76% | *ST生物 | 68.03% | 行业排名> |
| 2024-06-30 | 35.65% | -4.39% | 27.15% | 31/52 | 36.65% | 百奥赛图 | 74.42% | 行业排名> |
| 2024-03-31 | 28.04% | -14.3% | -34.47% | 35/52 | 35.74% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 42.79% | 24.26% | 6.91% | 19/52 | 38.77% | 百奥赛图 | 70.59% | 行业排名> |
| 2023-09-30 | 40.02% | 25.62% | 7.32% | 29/52 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 37.29% | 90.44% | 13.97% | 33/52 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 32.72% | 149.94% | -4.98% | 39/52 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 34.44% | -12.72% | 8.09% | 41/52 | 40.75% | 百奥赛图 | 73.38% | 行业排名> |
| 2022-09-30 | 31.86% | -8.78% | 62.7% | 37/52 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 19.58% | -31.73% | 49.57% | 46/52 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 13.09% | -17.93% | -66.82% | 40/52 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 39.46% | 6.26% | 12.98% | 33/52 | 42.48% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 34.92% | 20.72% | 21.76% | 30/52 | 43.07% | *ST生物 | 84.53% | 行业排名> |
| 2021-06-30 | 28.68% | 536.91% | 79.82% | 40/52 | 42.6% | *ST生物 | 83.19% | 行业排名> |
| 2021-03-31 | 15.95% | 132% | -57.04% | 30/52 | 39.47% | *ST生物 | 83.9% | 行业排名> |
| 2020-12-31 | 37.13% | -15.24% | 28.35% | 38/52 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 28.93% | -30.23% | 542.43% | 28/52 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 4.5% | -87.36% | 109.03% | 37/52 | 39.28% | *ST生物 | 78.74% | 行业排名> |
| 2020-03-31 | -49.85% | -345.32% | -213.79% | 32/52 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 43.81% | -7.89% | 5.65% | 21/52 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 41.47% | -10.51% | 16.42% | 16/52 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 35.62% | -20.25% | 75.28% | 26/52 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 20.32% | -35.72% | -57.27% | 28/52 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 47.56% | 1.47% | 2.64% | 11/52 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 46.34% | 5.92% | 3.75% | 11/52 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 44.66% | 10.6% | 41.27% | 17/52 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 31.61% | 43.18% | -32.55% | 24/52 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 46.87% | 3.19% | 7.14% | 11/52 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 43.75% | -0.49% | 8.34% | 12/52 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 40.38% | 6.16% | 82.89% | 18/52 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2017-03-31 | 22.08% | 224.66% | -51.39% | 19/52 | 38.7% | 海特生物 | 95.45% | 行业排名> |
| 2016-12-31 | 45.42% | -5.27% | 3.33% | 12/52 | 40.43% | 退市海医 | 96.32% | 行业排名> |
| 2016-09-30 | 43.96% | 2.42% | 15.58% | 7/52 | 37.08% | 海特生物 | 95.35% | 行业排名> |
| 2016-06-30 | 38.04% | -0.68% | 459.29% | 13/52 | 33.77% | 退市海医 | 95.27% | 行业排名> |
| 2016-03-31 | 6.8% | 314.28% | -85.82% | 18/52 | 28.42% | 盈康生命 | 75.69% | 行业排名> |